Supportive Care in Cancer Q2 Unclaimed
Why publish with us
We are published in partnership with the Multinational Association of Supportive Care in Cancer (MASCC), and are committed to ensuring high visibility for your publication through Society membership, libraries and social media.
Our journal is ranked #1 in the Google Scholar h5-Index of Hospice and Palliative Care, with a 2020 h5-Index of 55.
Through Springer Compact agreements, authors from participating institutions can publish Open Choice in our journal, at no cost to the authors.
Our helpful and supportive reviewers deliver high levels of author satisfaction, with 95% of our published authors reporting that they would definitely or probably publish with us again. It has an SJR impact factor of 0,984.
Supportive Care in Cancer focuses its scope in these topics and keywords: cancer, patients, care, palliative, breast, early, standard, treatment, trial, status, ...
Type of Copyright:
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3290 €Inmediate OA
0 €Non OA
0,984SJR Impact factor
1037Total Docs (Last Year)
2025Total Docs (3 years)
7224Total Cites (3 years)
1876Citable Docs (3 years)
3.35Cites/Doc (2 years)
Best articles by citations
Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trialsView more
The importance of clinical practice guidelines (CPGs) for the quality and development of supportive care in Central and Eastern European (CEE) countriesView more
Daily activities: exploring their spectrum and prognostic impact in older, chemotherapy-treated lung cancer patientsView more
Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trialsView more
The relationship between patient characteristics and carer psychological status in home palliative cancer careView more
Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized clinical trialsView more
Effectiveness of a teaching programme in pain and symptom management for junior house officersView more
Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancerView more
Granisetron in the control of nausea and vomiting associated with bone marrow transplantation: a review of its efficacy and tolerabilityView more
Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapyView more
Economic evaluation of antiaromatase agents in the second-line treatment of metastatic breast cancerView more
Defining optimal control of chemotherapy-induced nausea and vomiting - based on patients' experienceView more
A bedside food cart as an alternate food service for acute and palliative oncological patientsView more
Care of breast cancer in the elderly woman?what does comprehensive geriatric assessment (CGA) help?View more